Literature DB >> 21360611

The testosterone binding mechanism of an antibody derived from a naïve human scFv library.

Merja H Niemi1, Kristiina Takkinen, Lotta K Amundsen, Hans Söderlund, Juha Rouvinen, Matti Höyhtyä.   

Abstract

A testosterone binding scFv antibody was isolated from a naïve human library with a modest size of 10(8) clones. The crystal structure of the Fab fragment form of the 5F2 antibody clone complexed with testosterone determined at 1.5 Å resolution shows that the hapten is bound deeply in the antibody binding pocket. In addition to the interactions with framework residues only CDR-L3 and CDR-H3 loops interact with testosterone and the heavy chain forms the majority of the contacts with the hapten. The testosterone binding site of the 5F2 antibody with a high abundance of aromatic amino acid residues shows similarity with an in vitro affinity matured antibody having around 300 times higher affinity. The moderate affinity of the 5F2 antibody originates from the different orientation of the hapten and few light chain contacts. This is the first three-dimensional structure of a human steroid hormone binding antibody that has been isolated from a naïve human repertoire.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360611     DOI: 10.1002/jmr.1039

Source DB:  PubMed          Journal:  J Mol Recognit        ISSN: 0952-3499            Impact factor:   2.137


  7 in total

1.  Structural insights into a human anti-IFN antibody exerting therapeutic potential for systemic lupus erythematosus.

Authors:  Songying Ouyang; Bin Gong; Jin-Zhi Li; Li-Xia Zhao; Wei Wu; Fu-Shun Zhang; Lina Sun; Shu-Jun Wang; Meng Pan; Chuan Li; Wenguang Liang; Neil Shaw; Jie Zheng; Guo-Ping Zhao; Ying Wang; Zhi-Jie Liu; Mifang Liang
Journal:  J Mol Med (Berl)       Date:  2012-02-04       Impact factor: 4.599

2.  An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop.

Authors:  Sean W Fanning; James R Horn
Journal:  Protein Sci       Date:  2011-05-23       Impact factor: 6.725

3.  Somatic Mutations Modulate Autoantibodies against Galactose-Deficient IgA1 in IgA Nephropathy.

Authors:  Zhi Qiang Huang; Milan Raska; Tyler J Stewart; Colin Reily; R Glenn King; David K Crossman; Michael R Crowley; Audra Hargett; Zhixin Zhang; Hitoshi Suzuki; Stacy Hall; Robert J Wyatt; Bruce A Julian; Matthew B Renfrow; Ali G Gharavi; Jan Novak
Journal:  J Am Soc Nephrol       Date:  2016-03-10       Impact factor: 10.121

4.  Defining the complementarities between antibodies and haptens to refine our understanding and aid the prediction of a successful binding interaction.

Authors:  Mohammed M Al Qaraghuli; Soumya Palliyil; Gillian Broadbent; David C Cullen; Keith A Charlton; Andrew J Porter
Journal:  BMC Biotechnol       Date:  2015-10-24       Impact factor: 2.563

Review 5.  In situ click chemistry: from small molecule discovery to synthetic antibodies.

Authors:  Steven W Millward; Heather D Agnew; Bert Lai; Su Seong Lee; Jaehong Lim; Arundhati Nag; Suresh Pitram; Rosemary Rohde; James R Heath
Journal:  Integr Biol (Camb)       Date:  2013-01       Impact factor: 2.192

6.  Adaption of human antibody λ and κ light chain architectures to CDR repertoires.

Authors:  Rob van der Kant; Joschka Bauer; Anne R Karow-Zwick; Sebastian Kube; Patrick Garidel; Michaela Blech; Frederic Rousseau; Joost Schymkowitz
Journal:  Protein Eng Des Sel       Date:  2019-12-13       Impact factor: 1.650

7.  Isolation and characterization of malaria PfHRP2 specific VNAR antibody fragments from immunized shark phage display library.

Authors:  Chiuan Herng Leow; Katja Fischer; Chiuan Yee Leow; Katleen Braet; Qin Cheng; James McCarthy
Journal:  Malar J       Date:  2018-10-24       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.